Boehringer Ingelheim: Advancing anticoagulation care with new data at ESC Congress 2017
「The presentation of the results of our RE-DUAL PCI™ trial at ESC is particularly timely as the focus of the 2017 congress is 『40 years of PCI』」, commented Professor Jörg Kreuzer, Vice President Me......
